查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786872

伴隨式診斷(CDx)開發市場，規模，佔有率，趨勢，產業分析報告:各服務形式，分析方法，各目標治療領域，各終端用戶，各地區，2025年～2034年的市場預測

Companion Diagnostics Development Market Size, Share, Trends, Industry Analysis Report By Type of Service, By Analytical Technique, By Target Therapeutic Area, By End User, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，全球伴隨診斷 (CDx) 開發市場預計到 2034 年將達到 17.5579 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

伴隨診斷 (CDx) 開發市場圍繞著與特定治療藥物密切相關的專用診斷測試的研發和生產。這些測試對於提供關鍵資訊至關重要，有助於醫療保健專業人員確定哪些患者最有可能從特定治療中受益。透過識別特定的生物標記和基因特徵，CDx 可以確保個人化治療，從而提高藥物安全性和有效性，同時最大限度地降低副作用風險。這種藥物和診斷方法共同開發的方式是精準醫療的基礎，它推動醫療保健朝向更個人化、更有針對性的治療方向發展。

隨著全球對個人化醫療的追求以及疾病（尤其是癌症）日益複雜的現狀，伴隨診斷 (CDx) 開發市場正在經歷強勁增長。隨著更多標靶療法的開發，對用於識別合格患者群體的伴隨診斷 (CDx) 的需求也日益增長。分子生物學、基因組學和新一代定序 (NGS) 等分析技術的發展也推動了該領域的創新，使得新的生物標記物的發現和更精密的診斷工具的開發成為可能。監管機構在塑造伴隨診斷 (CDx) 市場方面發揮關鍵作用，它們為伴隨診斷 (CDx) 的聯合開發和審批提供指導，進一步將這些診斷技術融入主流醫療實踐。

伴隨診斷 (CDx) 發展市場報告重點：

按服務類型劃分，預計臨床驗證將在 2024 年佔據最大市場佔有率。這是因為它在證明診斷藥物在真實患者環境中的有效性方面發揮著至關重要的作用。可靠的臨床驗證對於監管審批至關重要，並確保檢測能夠準確預測患者對特定藥物的反應。

按分析方法劃分，預計聚合酶鍊式反應 (PCR) 將在 2024 年佔據最大市場佔有率。這是因為它可靠性高、成本效益高，並且在臨床實驗室中廣泛使用。它在檢測基因標靶方面具有高靈敏度和特異性，使其成為識別生物標記以指導標靶治療的基礎技術。

按目標治療領域劃分，預計腫瘤學將在2024年佔據最大的市場佔有率。這主要是因為各種癌症在全球範圍內的高發病率以及個人化醫療在癌症治療中的日益普及。伴隨診斷對於篩選對特定癌症療法反應最佳的患者至關重要。

按最終用戶劃分，由於在藥物研發方面的大量投資以及與伴隨診斷共同開發新型療法的內在需求，行業參與者將在2024年佔據顯著佔有率。產業參與者擁有豐富的資源和全球商業網絡，使他們能夠應對複雜的監管要求，從而促進伴隨診斷的普及。

按地區劃分，北美將在2024年佔據伴隨診斷市場的最大佔有率，這得益於其先進的醫療基礎設施、高昂的醫療成本以及鼓勵快速採用新診斷技術的有利監管環境。

伴隨診斷 (CDx) 開發市場包括羅氏公司 (F. Hoffmann-La Roche Ltd.)、凱傑公司 (QIAGEN N.V.)、安捷倫科技公司 (Agilent Technologies, Inc.)、雅培實驗室 (Abbott Laboratories)、Illumina 公司、Myriad Genetics 公司、Sysbbott Laboratories)、Illumina 公司、Myriad Genetics 公司、Sysmex Genex、Thix 飛世科技公司 (TheMx Genetics" 公司、飛世科技公司、飛默科技公司、飛默科技公司 (TheMx Genetics" Inc.)、Labcorp、Quest Diagnostics 和 Guardant Health, Inc.。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球伴隨式診斷(CDx)開發市場洞察

  • 市場概述
  • 伴隨式診斷(CDx)開發市場動態
    • 促進因素和機會
      • 個人化醫療的普及率不斷提高
      • 癌症發生率不斷上升
    • 限制與課題
      • 複雜且冗長的共同開發與審批流程
  • PESTEL分析
  • 伴隨式診斷(CDx)開發市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球伴隨式診斷(CDx)開發市場:各服務形式

  • 主要調查結果
  • 簡介
  • 可行性調查
  • 化驗開發
  • 分析檢驗
  • 臨床檢驗
  • 製造業

第6章 全球伴隨式診斷(CDx)開發市場:各分析技術

  • 主要調查結果
  • 簡介
  • NGS
  • PCR
  • IHC
  • 流式細胞技術
  • 其他

第7章 全球伴隨式診斷(CDx)開發市場:各目標治療領域

  • 主要調查結果
  • 簡介
  • 腫瘤性疾病
  • 非腫瘤性疾病

第8章 全球伴隨式診斷(CDx)開發市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 產業企業
  • 產業外企業

第9章 全球伴隨式診斷(CDx)開發市場:各地區

  • 主要調查結果
  • 簡介
    • 伴隨式診斷(CDx)開發市場評估:各地區，2020～2034年
  • 北美
    • 北美:各服務形式，2020～2034年
    • 北美:各分析技術，2020～2034年
    • 北美:各目標治療領域，2020年～2034年
    • 北美:各終端用戶，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各服務形式，2020～2034年
    • 歐洲:各分析技術，2020～2034年
    • 歐洲:各目標治療領域，2020～2034年
    • 歐洲:各終端用戶，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各服務形式，2020～2034年
    • 亞太地區:各分析方法，2020～2034年
    • 亞太地區:各目標治療領域，2020年～2034年
    • 亞太地區:各終端用戶，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各服務形式，2020～2034年
    • 中東·非洲:各分析方法，2020～2034年
    • 中東·非洲:各目標治療領域，2020年～2034年
    • 中東·非洲:各終端用戶，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各服務形式，2020～2034年
    • 南美:各分析方法，2020～2034年
    • 南美:各目標治療領域，2020年～2034年
    • 南美:各終端用戶，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Labcorp
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
Product Code: PM5955

The global companion diagnostics (CDx) development market size is expected to reach USD 1,755.79 million by 2034, according to a new study by Polaris Market Research. The report "Companion Diagnostics (Cdx) Development Market Size, Share, Trends, Industry Analysis Report By Type of Service (Feasibility Studies, Assay Development), By Analytical Technique, By Target Therapeutic Area, By End User, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The companion diagnostics (CDx) development market revolves around the creation and production of specialized diagnostic tests that are intricately linked with specific therapeutic drugs. These tests are vital for providing crucial information that guides healthcare professionals in determining which patients are most likely to benefit from a particular treatment. By identifying specific biomarkers or genetic characteristics, CDx ensures that treatments are tailored to individual patients, thereby enhancing both the safety and effectiveness of medications while minimizing the risk of adverse reactions. This co-development approach between a drug and its diagnostic is a cornerstone of precision medicine, moving healthcare toward more personalized and targeted interventions.

The companion diagnostics development market is experiencing strong growth, driven by a global push toward personalized medicine and the increasing complexity of diseases, especially cancer. As more targeted therapies are developed, the demand for CDx to identify eligible patient populations continues to rise. Advancements in molecular biology, genomics, and analytical techniques such as next-generation sequencing (NGS) are also fueling innovation in this sector, allowing for the discovery of new biomarkers and the development of more sophisticated diagnostic tools. Regulatory agencies play a key role in shaping this market by providing guidelines for the co-development and approval of CDx, further integrating these diagnostics into mainstream medical practice.

Companion Diagnostics Development Market Report Highlights:

By type of service, the clinical validation segment held the largest share in 2024 due to its essential role in demonstrating a diagnostic's effectiveness in real-world patient settings. Robust clinical validation is critical for regulatory approval, ensuring the test accurately predicts patient response to a specific drug.

By analytical technique, the polymerase chain reaction (PCR) segment held the largest share in 2024 owing to its proven reliability, cost-effectiveness, and widespread use in clinical labs. Its high sensitivity and specificity in detecting genetic targets make it a fundamental technology for identifying biomarkers that guide targeted therapies.

By target therapeutic area, the oncological disorders segment held the largest share in 2024, primarily driven by the high global prevalence of various cancers and the increasing adoption of personalized medicine in cancer treatment. Companion diagnostics are vital for selecting patients who will best respond to specific cancer therapies.

By end user, the industry players segment held a larger share in 2024 due to their significant investments in drug discovery and their inherent need to co-develop CDx alongside new therapeutics. Their extensive resources and global commercial networks enable them to navigate complex regulatory requirements and drive CDx adoption.

By region, North America held the largest share of the global companion diagnostics market in 2024, benefiting from its advanced healthcare infrastructure, high healthcare spending, and a supportive regulatory environment that encourages the rapid adoption of new diagnostic technologies.

The companion diagnostics development market includes active players such as F. Hoffmann-La Roche Ltd.; QIAGEN N.V.; Agilent Technologies, Inc.; Abbott Laboratories; Illumina, Inc.; Myriad Genetics, Inc.; Sysmex Corporation; BioMerieux SA; Thermo Fisher Scientific Inc.; Labcorp; Quest Diagnostics; and Guardant Health, Inc.

Polaris Market Research has segmented the CDx development market report on the basis of type of service, analytical technique, target therapeutic area, end user, and region:

By Type of Service Outlook (Revenue - USD Million, 2020-2034)

Feasibility Studies

Assay Development

Analytical Validation

Clinical Validation

Manufacturing

By Analytical Technique Outlook (Revenue - USD Million, 2020-2034)

NGS

PCR

IHC

Flow Cytometry

Others

By Target Therapeutic Area Outlook (Revenue - USD Million, 2020-2034)

Oncological Disorders

Non-oncological Disorders

By End User Outlook (Revenue - USD Million, 2020-2034)

Industry Players

Non-Industry Players

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Companion Diagnostics (Cdx) Development Market Insights

  • 4.1. Companion Diagnostics (Cdx) Development Market - Market Snapshot
  • 4.2. Companion Diagnostics (Cdx) Development Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Adoption of Personalized Medicine
      • 4.2.1.2. Rising Incidence of Cancer
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex and lengthy co-development and approval processes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Companion Diagnostics (Cdx) Development Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Companion Diagnostics (Cdx) Development Market, by Type of Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • 5.3. Feasibility Studies
    • 5.3.1. Global Companion Diagnostics (Cdx) Development Market, by Feasibility Studies, by Region, 2020-2034 (USD Million)
  • 5.4. Assay Development
    • 5.4.1. Global Companion Diagnostics (Cdx) Development Market, by Assay Development, by Region, 2020-2034 (USD Million)
  • 5.5. Analytical Validation
    • 5.5.1. Global Companion Diagnostics (Cdx) Development Market, by Analytical Validation, by Region, 2020-2034 (USD Million)
  • 5.6. Clinical Validation
    • 5.6.1. Global Companion Diagnostics (Cdx) Development Market, by Clinical Validation, by Region, 2020-2034 (USD Million)
  • 5.7. Manufacturing
    • 5.7.1. Global Companion Diagnostics (Cdx) Development Market, by Manufacturing, by Region, 2020-2034 (USD Million)

6. Global Companion Diagnostics (Cdx) Development Market, by Analytical Technique

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • 6.3. NGS
    • 6.3.1. Global Companion Diagnostics (Cdx) Development Market, by NGS, by Region, 2020-2034 (USD Million)
  • 6.4. PCR
    • 6.4.1. Global Companion Diagnostics (Cdx) Development Market, by PCR, by Region, 2020-2034 (USD Million)
  • 6.5. IHC
    • 6.5.1. Global Companion Diagnostics (Cdx) Development Market, by IHC, by Region, 2020-2034 (USD Million)
  • 6.6. Flow Cytometry
    • 6.6.1. Global Companion Diagnostics (Cdx) Development Market, by Flow Cytometry, by Region, 2020-2034 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Companion Diagnostics (Cdx) Development Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • 7.3. Oncological Disorders
    • 7.3.1. Global Companion Diagnostics (Cdx) Development Market, by Oncological Disorders, by Region, 2020-2034 (USD Million)
  • 7.4. Non-oncological Disorders
    • 7.4.1. Global Companion Diagnostics (Cdx) Development Market, by Non-oncological Disorders, by Region, 2020-2034 (USD Million)

8. Global Companion Diagnostics (Cdx) Development Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 8.3. Industry Players
    • 8.3.1. Global Companion Diagnostics (Cdx) Development Market, by Industry Players, by Region, 2020-2034 (USD Million)
  • 8.4. Non-Industry Players
    • 8.4.1. Global Companion Diagnostics (Cdx) Development Market, by Non-Industry Players, by Region, 2020-2034 (USD Million)

9. Global Companion Diagnostics (Cdx) Development Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Companion Diagnostics (Cdx) Development Market Assessment, By Geography, 2020-2034 (USD Million)
  • 9.3. Companion Diagnostics (Cdx) Development Market - North America
    • 9.3.1. North America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.3.2. North America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.3.3. North America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.3.4. North America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.3.5. Companion Diagnostics (Cdx) Development Market - US
      • 9.3.5.1. US: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.3.5.2. US: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.3.5.3. US: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.3.5.4. US: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.3.6. Companion Diagnostics (Cdx) Development Market - Canada
      • 9.3.6.1. Canada: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.3.6.2. Canada: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.3.6.3. Canada: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.3.6.4. Canada: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 9.4. Companion Diagnostics (Cdx) Development Market - Europe
    • 9.4.1. Europe: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.4.2. Europe: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.4.3. Europe: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.4.4. Europe: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.5. Companion Diagnostics (Cdx) Development Market - UK
      • 9.4.5.1. UK: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.5.2. UK: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.5.3. UK: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.5.4. UK: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.6. Companion Diagnostics (Cdx) Development Market - France
      • 9.4.6.1. France: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.6.2. France: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.6.3. France: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.6.4. France: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.7. Companion Diagnostics (Cdx) Development Market - Germany
      • 9.4.7.1. Germany: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.7.2. Germany: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.7.3. Germany: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.7.4. Germany: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.8. Companion Diagnostics (Cdx) Development Market - Italy
      • 9.4.8.1. Italy: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.8.2. Italy: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.8.3. Italy: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.8.4. Italy: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.9. Companion Diagnostics (Cdx) Development Market - Spain
      • 9.4.9.1. Spain: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.9.2. Spain: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.9.3. Spain: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.9.4. Spain: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.10. Companion Diagnostics (Cdx) Development Market - Netherlands
      • 9.4.10.1. Netherlands: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.10.2. Netherlands: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.10.3. Netherlands: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.10.4. Netherlands: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.11. Companion Diagnostics (Cdx) Development Market - Russia
      • 9.4.11.1. Russia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.11.2. Russia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.11.3. Russia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.11.4. Russia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.12. Companion Diagnostics (Cdx) Development Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.12.2. Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.12.3. Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.12.4. Rest of Europe: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 9.5. Companion Diagnostics (Cdx) Development Market - Asia Pacific
    • 9.5.1. Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.5.2. Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.5.3. Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.5.4. Asia Pacific: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.5. Companion Diagnostics (Cdx) Development Market - China
      • 9.5.5.1. China: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.5.2. China: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.5.3. China: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.5.4. China: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.6. Companion Diagnostics (Cdx) Development Market - India
      • 9.5.6.1. India: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.6.2. India: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.6.3. India: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.6.4. India: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.7. Companion Diagnostics (Cdx) Development Market - Malaysia
      • 9.5.7.1. Malaysia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.7.2. Malaysia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.7.3. Malaysia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.7.4. Malaysia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.8. Companion Diagnostics (Cdx) Development Market - Japan
      • 9.5.8.1. Japan: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.8.2. Japan: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.8.3. Japan: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.8.4. Japan: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.9. Companion Diagnostics (Cdx) Development Market - Indonesia
      • 9.5.9.1. Indonesia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.9.2. Indonesia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.9.3. Indonesia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.9.4. Indonesia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.10. Companion Diagnostics (Cdx) Development Market - South Korea
      • 9.5.10.1. South Korea: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.10.2. South Korea: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.10.3. South Korea: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.10.4. South Korea: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.11. Companion Diagnostics (Cdx) Development Market - Australia
      • 9.5.11.1. Australia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.11.2. Australia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.11.3. Australia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.11.4. Australia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.12. Companion Diagnostics (Cdx) Development Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 9.6. Companion Diagnostics (Cdx) Development Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.6.2. Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.6.3. Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.6.4. Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.5. Companion Diagnostics (Cdx) Development Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.5.2. Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.5.3. Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.5.4. Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.6. Companion Diagnostics (Cdx) Development Market - UAE
      • 9.6.6.1. UAE: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.6.2. UAE: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.6.3. UAE: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.6.4. UAE: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.7. Companion Diagnostics (Cdx) Development Market - Israel
      • 9.6.7.1. Israel: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.7.2. Israel: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.7.3. Israel: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.7.4. Israel: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.8. Companion Diagnostics (Cdx) Development Market - South Africa
      • 9.6.8.1. South Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.8.2. South Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.8.3. South Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.8.4. South Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.9. Companion Diagnostics (Cdx) Development Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 9.7. Companion Diagnostics (Cdx) Development Market - Latin America
    • 9.7.1. Latin America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.7.2. Latin America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.7.3. Latin America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.7.4. Latin America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.7.5. Companion Diagnostics (Cdx) Development Market - Mexico
      • 9.7.5.1. Mexico: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.7.5.2. Mexico: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.7.5.3. Mexico: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.7.5.4. Mexico: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.7.6. Companion Diagnostics (Cdx) Development Market - Brazil
      • 9.7.6.1. Brazil: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.7.6.2. Brazil: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.7.6.3. Brazil: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.7.6.4. Brazil: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.7.7. Companion Diagnostics (Cdx) Development Market - Argentina
      • 9.7.7.1. Argentina: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.7.7.2. Argentina: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.7.7.3. Argentina: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.7.7.4. Argentina: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.7.8. Companion Diagnostics (Cdx) Development Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.7.8.2. Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.7.8.3. Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.7.8.4. Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Agilent Technologies, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. BioMerieux SA
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. F. Hoffmann-La Roche Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Guardant Health, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Illumina, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Labcorp
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Myriad Genetics, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. QIAGEN N.V.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Quest Diagnostics
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Sysmex Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Thermo Fisher Scientific Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 2 Global Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 3 Global Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 4 Global Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 5 North America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 6 North America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 7 North America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 8 North America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 9 U.S.: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 10 U.S.: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 11 U.S.: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 12 U.S.: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 13 Canada: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 14 Canada: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 15 Canada: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 16 Canada: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 17 Europe: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 18 Europe: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 19 Europe: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 20 Europe: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 21 UK: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 22 UK: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 23 UK: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 24 UK: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 25 France: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 26 France: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 27 France: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 28 France: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 29 Germany: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 30 Germany: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 31 Germany: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 32 Germany: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 33 Italy: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 34 Italy: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 35 Italy: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 36 Italy: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 37 Spain: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 38 Spain: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 39 Spain: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 40 Spain: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 41 Netherlands: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 42 Netherlands: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 43 Netherlands: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 44 Netherlands: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 45 Russia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 46 Russia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 47 Russia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 48 Russia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 49 Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 50 Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 51 Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 52 Rest of Europe: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 53 Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 54 Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 55 Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 56 Asia Pacific: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 57 China: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 58 China: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 59 China: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 60 China: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 61 India: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 62 India: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 63 India: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 64 India: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 65 Malaysia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 66 Malaysia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 67 Malaysia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 68 Malaysia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 69 Japan: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 70 Japan: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 71 Japan: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 72 Japan: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 73 Indonesia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 74 Indonesia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 75 Indonesia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 76 Indonesia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 77 South Korea: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 78 South Korea: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 79 South Korea: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 80 South Korea: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 81 Australia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 82 Australia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 83 Australia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 84 Australia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 85 Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 86 Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 87 Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 88 Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 89 Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 90 Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 91 Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 92 Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 93 Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 94 Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 95 Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 96 Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 97 UAE: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 98 UAE: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 99 UAE: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 100 UAE: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 101 Israel: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 102 Israel: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 103 Israel: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 104 Israel: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 105 South Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 106 South Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 107 South Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 108 South Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 109 Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 110 Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 111 Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 112 Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 113 Latin America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 114 Latin America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 115 Latin America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 116 Latin America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 117 Mexico: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 118 Mexico: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 119 Mexico: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 120 Mexico: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 121 Brazil: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 122 Brazil: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 123 Brazil: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 124 Brazil: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 125 Argentina: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 126 Argentina: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 127 Argentina: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 128 Argentina: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 129 Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 130 Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 131 Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 132 Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Companion Diagnostics (Cdx) Development Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type of Service
  • Figure 7. Global Companion Diagnostics (Cdx) Development Market, by Type of Service, 2024 & 2034 (USD Million)
  • Figure 8. Market by Analytical Technique
  • Figure 9. Global Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2024 & 2034 (USD Million)
  • Figure 10. Market by Target Therapeutic Area
  • Figure 11. Global Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2024 & 2034 (USD Million)
  • Figure 12. Market by End User
  • Figure 13. Global Companion Diagnostics (Cdx) Development Market, by End User, 2024 & 2034 (USD Million)